The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

Ozempic Linked With Lower Dementia Risk, Nicotine Use, British Study Finds. More. Reuters. FILE PHOTO: A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31 ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Not one but two new studies published today have linked GLP-1 drugs like Ozempic to a decreased risk of developing dementia. There is currently no cure for Alzheimer’s, which affects an ...

Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular weight loss drugs like Ozempic and Wegovy — may be linked to ...

New research suggests that the diabetes drug and popular weight loss treatment semaglutide, commonly known as Ozempic and Wegovy, is linked with a lower risk of dementia — possibly adding to the ...

Ozempic linked with lower dementia risk, nicotine use, British study finds. By Reuters. July 12, 2024 5:49 PM UTC Updated July 12, 2024 A box of Ozempic and contents sit on a table ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

Ozempic and similar novel diabetes treatments may lower the risk of Alzheimer's disease and related dementias.. This is the conclusion of a pair of studies by research teams from the U.S. and ...

According to a study published on October 24, 2024, in the journal Alzheimer’s & Dementia, the type 2 diabetes and weight loss drug semaglutide (sold under the brand names Ozempic, Wegovy, and ...